PubMed · 2026-05-28
Researchers review how combining metal nanoparticles made using plant extracts with plant-derived compounds (like galantamine from snowdrops) could offer more effective treatments for Alzheimer's disease by blocking the enzyme that breaks down a key memory-related brain chemical.
Only one of the three FDA-approved Alzheimer's drugs (galantamine) is a naturally occurring plant alkaloid, derived from species including snowdrops (Galanthus) and daffodils (Narcissus).
Green synthesis uses plant-derived compounds to produce metal nanoparticles, combining the particles' physical properties with the therapeutic activity of the plant metabolites in a single agent.
The review identifies synergistic potential between metal nanoparticles and plant metabolites as a promising frontier, though no clinical trials are yet reported — findings remain at the research and review stage.
